MILWAUKEE , Oct. 9, 2025 /PRNewswire/ -- The Ademi Firm is investigating Akero (NASDAQ: AKRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Nordisk. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

MIAMI, Oct. 09, 2025 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 100 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today provided the following corporate updated on its progress. Market Acceptance, Progress and Recent Events: After reporting 15.7 million in cash and cash equivalents as of June 30, 2025, SKYX has raised an additional $3.25 million in September from an existing lead investor.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its third quarter 2025 conference call. The Company will issue a press release announcing its results on Thursday, October 23, 2025, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Friday, October 24, 2025. During this call, Community Health Systems will review the Company's financial and operating.

CHICAGO--(BUSINESS WIRE)--Amrize will issue Q3 earnings results after market close on 10/28 with an earnings call on 10/29.

Opening Bid executive editor Brian Sozzi breaks down the latest October 9, 2025 market moves. Brian speaks to our panel about the latest Delta and PepsiCo earnings results.

Nuclear technology stock Oklo Inc (NYSE:OKLO) is on the rise today, up 3.6% at $139.38 at last glance, after Canaccord Genuity initiated coverage with a "buy" rating and price target of $175.

Black Diamonds shares surge 86.4% in 2025 as strong silevertinib data and rising estimates fuel optimism for further gains.

XYZ's Square strengthens its food and beverage platform with AI, voice ordering, and bitcoin payments to help restaurants scale smarter and operate efficiently.

The mean of analysts' price targets for Fiverr (FVRR) points to a 33.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 47.4% upside potential for Mission Produce (AVO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wex (WEX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 280.1% in MBX Biosciences, Inc. (MBX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The image featured for this article is © mezzotint / Shutterstock.com

Delta Air Lines (DAL) reported record third-quarter revenue and issued a rosy outlook, driven by higher premium and corporate travel sales.

Microsoft is reportedly intensifying efforts to carve a space for itself in artificial intelligence. The tech giant wants to become an AI chatbot force on its own, beyond its longtime partnership with OpenAI, The Wall Street Journal reported Thursday (Oct. 9).

Mr. Market's bullish sentiment towards Biogen is returning. One reason for this is its strengthening position in the multiple sclerosis drugs market, thanks to Vumerity, whose sales reached $212.3 million in Q2 2025, up 28% year-on-year. Also, Biogen's EBIT margin has continued to grow over the past four quarters, reaching 34.6% for the three months ended June 30, 2025.

HWM stock soars 87.7% in a year on strong aerospace demand and defense gains, but high costs and valuation may curb near-term upside.

BKD's September weighted average consolidated occupancy rate hits 82.5%, up 330 bps YoY. The metric signals a year-over-year rise of 290 bps in third-quarter 2025.

SONO rides a powerful rally with new product momentum and global expansion plans.

AIT builds momentum through automation and acquisitions, though higher costs and weak service demand pose near-term risks.